Starting ADHD Medications May Lower Death Risk
For patients with attention-deficit/hyperactivity disorder (ADHD), starting medication was associated with a significantly lower risk of death, particularly from "unnatural" causes, according to an observational Swedish study. Among nearly 150,000 Swedish patients with ADHD, medication initiation was associated with a significantly lower rate of all-cause mortality over 2 years (HR 0.79, 95% CI 0.70-0.88) compared with not starting treatment, according to Zheng Chang, PhD, of the Karolinska Institute in Stockholm, and colleagues.
Other Articles in this Edition
No End in Sight for National ADHD Drug Shortage
Starting ADHD Medications May Lower Death Risk
NIH researchers identify brain connections associated with ADHD in youth
Taking “study drugs” can lead to other drug use and decline in mental health
Sleep Disordered Breathing Likely Exacerbates ADHD Symptoms
Do ADHD Meds Lead to Addiction?
Navigating the current shortages of pediatric ADHD medications
Prenatal cannabis exposure linked to heightened risk of ADHD symptoms
Lack of focus doesn’t equal lack of intelligence: It’s proof of an intricate brain, say scientists
Positive, Intentional Supports for Students With ADHD